These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29057167)

  • 21. Clinical pharmacogenomics of warfarin and clopidogrel.
    Shin J
    J Pharm Pract; 2012 Aug; 25(4):428-38. PubMed ID: 22674970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics in Oral Antithrombotic Therapy.
    Maier CL; Duncan A; Hill CE
    Clin Lab Med; 2016 Sep; 36(3):461-72. PubMed ID: 27514462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
    Cavallari LH; Mason DL
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.
    Yang Y; Lewis JP; Hulot JS; Scott SA
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1599-617. PubMed ID: 26173871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will personalized drugs for cardiovascular disease become an option? - Defining 'Evidence-based personalized medicine' for its implementation and future use.
    de Denus S; Dubé MP; Tardif JC
    Expert Opin Pharmacother; 2015; 16(17):2549-52. PubMed ID: 26371722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort.
    Mukherjee C; Sweet KM; Luzum JA; Abdel-Rasoul M; Christman MF; Kitzmiller JP
    Per Med; 2017 Sep; 14(5):383-388. PubMed ID: 29181084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of pharmacogenetics: focusing on practical issues.
    Chang MT; McCarthy JJ; Shin J
    Pharmacogenomics; 2015; 16(15):1733-41. PubMed ID: 26411302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based pharmacogenetics: Is it possible?
    Sychev DA; Malova EU
    Int J Risk Saf Med; 2015; 27 Suppl 1():S97-8. PubMed ID: 26639733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cases in Precision Medicine: The Role of Pharmacogenetics in Precision Prescribing.
    Lin B; Chung WK
    Ann Intern Med; 2019 Jun; 170(11):796-804. PubMed ID: 31108507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Pandrangi PV; Chahine A; Ahmed S; Osman K; Bachuwa G; Hassan M; Bhatt DL
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1246-1252. PubMed ID: 30403317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of cardiovascular pharmacogenetics.
    Voora D; Ginsburg GS
    J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
    Voora D; Eby C; Linder MW; Milligan PE; Bukaveckas BL; McLeod HL; Maloney W; Clohisy J; Burnett RS; Grosso L; Gatchel SK; Gage BF
    Thromb Haemost; 2005 Apr; 93(4):700-5. PubMed ID: 15841315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.
    Ross S; Paré G
    Pharmacogenomics; 2013 Oct; 14(13):1565-72. PubMed ID: 24088127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
    Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
    PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics and oral antithrombotic drugs.
    Baker WL; Johnson SG
    Curr Opin Pharmacol; 2016 Apr; 27():38-42. PubMed ID: 26878737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized medicine: potential, barriers and contemporary issues.
    Sorich MJ; McKinnon RA
    Curr Drug Metab; 2012 Sep; 13(7):1000-6. PubMed ID: 22591350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.